Tactile Systems Technology, Inc. (TCMD)
Tactile Systems Technology, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Minneapolis, MN, US. The stock last traded at $24.34, up 0.77% on the session, giving a market capitalisation of $548.9M. On trailing twelve-month figures it carries a trailing P/E of 22.12, a net margin of 7.1%. Its beta of 0.80 implies it has historically moved less than the broad market.
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.
Tactile Systems Technology, Inc. is most often compared with the following Healthcare names: